GW7647 |
GW7647 : Agonist of PPARA
Probe Summary
Selectivity
Potency
In Vivo
Control Compounds
Chemical Information
References
Vendors
Download
Probe Summary
| Targets | Biochemical/Biophysical Potency | Cellular Potency |
|---|---|---|
| PPARA |
|
|
Agonist
up to 1 uM
Selectivity
In Vitro Selectivity Assessment
Potency Assay Off-Target:
Selectivity >100-fold over PPARγ and PPARδ
EC50 1100 nM PPARγ
EC50 6200 nM PPARδ
Potency Cellular
In Vitro
PPARA
Mode of Action: Agonist
Structure-Activity-Relationship data available? Yes
DOI Reference: 10.1016/S0960-894X(01)00188-3
In Vivo Validations
Rat
Dose: 3 mg/Kg BID
Route of delivery:
Oral
Target engagement assay:
Oral administration to cholesterol/cholic acid-fed rats5 for 4 days resulted in a 60% increase in HDL-cholesterol, a 60% decrease in triglycerides, and a 40% decrease in serum apolipoprotein CIII.
DOI Reference: 10.1016/S0960-894X(01)00188-3
Hamster
Dose: 3 mg/Kg BID
Route of delivery:
Oral
Target engagement assay:
Oral administration to cholesterol/cholic acid-fed hamsters for 7 days resulted in a 93% decrease in triglycerides.
DOI Reference: 10.1016/S0960-894X(01)00188-3
Chemical Information
| Molecular Formula | C29H46N2O3S |
| SMILEs | CC(C)(Sc1ccc(CCN(CCCCC2CCCCC2)C(=O)NC2CCCCC2)cc1)C(=O)O |
| InChI | InChI=1S/C29H46N2O3S/c1-29(2,27(32)33)35-26-18-16-24(17-19-26)20-22-31(28(34)30-25-14-7-4-8-15-25)21-10-9-13-23-11-5-3-6-12-23/h16-19,23,25H,3-15,20-22H2,1-2H3,(H,30,34)(H,32,33) |
| Molecular weight | 502.32 Da |
| AlogP | 0.0 |
| HBond acceptors | 5 |
| HBond donors | 2 |
| Atoms | 81 |
Vendors
Note: This is not an exhaustive list and does not indicate endorsement by the portal.